Predicted risks of radiogenic cardiac toxicity in two pediatric patients undergoing photon or proton radiotherapy

Radiation Oncology

Volumn 8, Issue 1, 2013, Pages

  Zhang, Rui ^a,b,e   Howell, Rebecca M ^a,b   Homann, Kenneth ^a,b   Giebeler, Annelise ^a,b   Taddei, Phillip J ^a,b,c   Mahajan, Anita ^b   Newhauser, Wayne D ^a,b,d,e  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^d LOUISIANA STATE UNIVERSITY   (United States)

^e MARY BIRD PERKINS CANCER CENTER   (United States)

Author keywords

Cardiac toxicity; Craniospinal irradiation; Hodgkin disease; Mediastinal irradiation; Medulloblastoma; Normal tissue complication probability; Proton therapy

Indexed keywords

ARTICLE; BONE GROWTH; CARDIOTOXICITY; CASE REPORT; CHILD; COMPUTER ASSISTED TOMOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; HEART MUSCLE; HODGKIN DISEASE; HUMAN; MALE; MEDULLOBLASTOMA; NEUTRON; NEUTRON DOSIMETRY; PERICARDIUM; PHOTON; PHOTON THERAPY; PRESCHOOL CHILD; PROTON RADIATION; PROTON THERAPY; PULMONARY ARTERY; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION INJURY; RELATIVE BIOLOGIC EFFECTIVENESS; RISK FACTOR; SCHOOL CHILD; TREATMENT PLANNING;

CHILD; CHILD, PRESCHOOL; FEMALE; HEART; HODGKIN DISEASE; HUMANS; MALE; MEDIASTINUM; MEDULLOBLASTOMA; MYOCARDIUM; NEUTRONS; PERICARDIUM; PHOTONS; PROBABILITY; PROTONS; RADIATION INJURIES; RADIOTHERAPY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RISK; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84880335591     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-8-184     Document Type: Article

References (36)

1. Hull MC, Morris CG, Pepine CJ, Mendenhall NP. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy. JAMA 2003, 290:2831-2837. 10.1001/jama.290.21.2831, 14657067.
2. Aleman BM, van den Belt-Dusebout AW, Klokman WJ, Van't Veer MB, Bartelink H, van Leeuwen FE. Long-term cause-specific mortality of patients treated for Hodgkin's disease. J Clin Oncol 2003, 21:3431-3439. 10.1200/JCO.2003.07.131, 12885835.
3. Ng AK. Review of the cardiac long-term effects of therapy for Hodgkin lymphoma. Br J Haematol 2011, 154:23-31. 10.1111/j.1365-2141.2011.08713.x, 21539537.
4. Jakacki RI, Goldwein JW, Larsen RL, Barber G, Silber JH. Cardiac dysfunction following spinal irradiation during childhood. J Clin Oncol 1993, 11:1033-1038.
5. Gurney JG, Kadan-Lottick NS, Packer RJ, Neglia JP, Sklar CA, Punyko JA, Stovall M, Yasui Y, Nicholson HS, Wolden S, et al. Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study. Cancer 2003, 97:663-673. 10.1002/cncr.11095, 12548609.
6. Miralbell R, Lomax A, Cella L, Schneider U. Potential Reduction of the Incidence of Radiation-Induced Second Cancers by using Proton Beams in the Treatment of Pediatric Tumors. Int J Radiat Oncol Biol Phys 2002, 54:824-829. 10.1016/S0360-3016(02)02982-6, 12377335.
7. Hall EJ. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 2006, 65:1-7. 10.1016/j.ijrobp.2006.01.027, 16618572.
8. Newhauser WD, Fontenot JD, Mahajan A, Kornguth D, Stovall M, Zheng Y, Taddei PJ, Mirkovic D, Mohan R, Cox JD, Woo S. The risk of developing a second cancer after receiving craniospinal proton irradiation. Phys Med Biol 2009, 54:2277-2291. 10.1088/0031-9155/54/8/002, 19305036.
9. Jiang H, Wang B, Xu XG, Suit HD, Paganetti H. Simulation of organ-specific patient effective dose due to secondary neutrons in proton radiation treatment. Phys Med Biol 2005, 50:4337-4353. 10.1088/0031-9155/50/18/007, 16148397.
10. Taddei PJ, Mahajan A, Mirkovic D, Zhang R, Giebeler A, Kornguth D, Harvey M, Woo S, Newhauser WD. Predicted risks of second malignant neoplasm incidence and mortality due to secondary neutrons in a girl and boy receiving proton craniospinal irradiation. Phys Med Biol 2010, 55:7067-7080. 10.1088/0031-9155/55/23/S08, 3001324, 21076189.
11. Brodin NP, Rosenschold PM, Aznar MC, Kiil-Berthelsen A, Vogelius IR, Nilsson P, Lannering B, Bjork-Eriksson T. Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma. Acta Oncol 2011, 50:806-816. 10.3109/0284186X.2011.582514, 21767178.
12. Mu X, Bjoerk-Eriksson T, Nill S, Oelfke U, Johansson K-A, Gagliardi G, Johansson L, Karlsson M, Zackrisson DB. Does electron and proton therapy reduce the risk of radiation induced cancer after spinal irradiation for childhood medulloblastoma? A comparative treatment planning study. Acta Oncol 2005, 44:554-562. 10.1080/02841860500218819, 16165914.
13. Taddei PJ, Howell RM, Krishnan S, Scarboro SB, Mirkovic D, Newhauser WD. Risk of second malignant neoplasm following proton versus intensity-modulated photon radiotherapies for hepatocellular carcinoma. Phys Med Biol 2010, 55:7055-7065. 10.1088/0031-9155/55/23/S07, 3001302, 21076199.
14. Giebeler A, Newhauser WD, Amos RA, Mahajan A, Homann K, Howell RM. Standardized treatment planning methodology for passively scattered proton craniospinal irradiation. Radiat Oncol 2013, 8:32. 10.1186/1748-717X-8-32, 3606426, 23375151.
15. Howell RM, Giebeler A, Koontz-Raisig W, Mahajan A, Etzel CJ, D'Amelio AM, Homann KL, Newhauser WD. Comparison of therapeutic dosimetric data from passively scattered proton and photon craniospinal irradiations for medulloblastoma. Radiat Oncol 2012, 7:116-127. 10.1186/1748-717X-7-116, 3430590, 22828073.
16. ICRU Prescribing, recording and reporting photon beam therapy, ICRU report 50 1993, Bethesda, MD: International Commission on Radiation Units and Measurements, ICRU.
17. Hendricks JS, McKinney GW, Durkee JW, Finch JP, Fensin ML, James MR, Johns RC, Pelowitz DB, Waters LS, Gallmeier FX. MCNPX, Version 26c 2006, Los Alamos, NM: Los Alamos National Laboratory.
18. Howell RM, Scarboro SB, Taddei PJ, Krishnan S, Kry SF, Newhauser WD. Methodology for determining doses to in-field, out-of-field and partially in-field organs for late effects studies in photon radiotherapy. Phys Med Biol 2010, 55:7009-7023. 10.1088/0031-9155/55/23/S04, 3001332, 21076193.
19. Taddei PJ, Mirkovic D, Fontenot JD, Giebeler A, Zheng Y, Kornguth D, Mohan R, Newhauser WD. Stray radiation dose and second cancer risk for a pediatric patient receiving craniospinal irradiation with proton beams. Phys Med Biol 2009, 54:2259-2275. 10.1088/0031-9155/54/8/001, 19305045.
20. Tukenova M, Guibout C, Oberlin O, Doyon F, Mousannif A, Haddy N, Guerin S, Pacquement H, Aouba A, Hawkins M, et al. Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer. J Clin Oncol 2010, 28:1308-1315. 10.1200/JCO.2008.20.2267, 20142603.
21. Kallman P, Agren A, Brahme A. Tumour and normal tissue responses to fractionated non-uniform dose delivery. Int J Radiat Biol 1992, 62:249-262. 10.1080/09553009214552071, 1355519.
22. Lyman JT. Complication probability as assessed from dose-volume histograms. Radiat Res Suppl 1985, 8:S13-S19.
23. Eriksson F, Gagliardi G, Liedberg A, Lax I, Lee C, Levitt S, Lind B, Rutqvist LE. Long-term cardiac mortality following radiation therapy for Hodgkin's disease: analysis with the relative seriality model. Radiother Oncol 2000, 55:153-162. 10.1016/S0167-8140(00)00166-3, 10799727.
24. Gagliardi G, Lax I, Rutqvist LE. Partial irradiation of the heart. Semin Radiat Oncol 2001, 11:224-233. 10.1053/srao.2001.23483, 11447579.
25. Martel MK, Sahijdak WM, Ten Haken RK, Kessler ML, Turrisi AT. Fraction size and dose parameters related to the incidence of pericardial effusions. Int J Radiat Oncol Biol Phys 1998, 40:155-161. 10.1016/S0360-3016(97)00584-1, 9422572.
26. Burman C, Kutcher GJ, Emami B, Goitein M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 1991, 21:123-135.
27. Steel GG. Basic clinical radiobiology 2002, New York: Oxford University Press Inc.
28. ICRP Relative Biological Effectiveness, Radiation Weighting and Quality Factor. ICRP Publication 92. Ann ICRP 2003, 33:1-117. ICRP.
29. Wei X, Liu HH, Tucker SL, Wang S, Mohan R, Cox JD, Komaki R, Liao Z. Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy. Int J Radiat Oncol Biol Phys 2008, 70:707-714. 10.1016/j.ijrobp.2007.10.056, 18191334.
30. Mulrooney DA, Yeazel MW, Kawashima T, Mertens AC, Mitby P, Stovall M, Donaldson SS, Green DM, Sklar CA, Robison LL, Leisenring WM. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ 2009, 339:b4606. 10.1136/bmj.b4606, 3266843, 19996459.
31. Schultz-Hector S, Trott KR. Radiation-induced cardiovascular diseases: is the epidemiologic evidence compatible with the radiobiologic data?. Int J Radiat Oncol Biol Phys 2007, 67:10-18. 10.1016/j.ijrobp.2006.08.071, 17189062.
32. Chera BS, Rodriguez C, Morris CG, Louis D, Yeung D, Li Z, Mendenhall NP. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy. Int J Radiat Oncol Biol Phys 2009, 75:1173-1180. 10.1016/j.ijrobp.2008.12.048, 19386423.
33. Hoppe BS, Flampouri S, Lynch J, Slayton W, Zaiden R, Li Z, Mendenhall NP. Improving the therapeutic ratio in Hodgkin lymphoma through the use of proton therapy. Oncology (Williston Park) 2012, 26:456-459. 462-455.
34. Fuss M, Poljanc K, Miller DW, Archambeau JO, Slater JM, Slater JD, Hug EB. Normal tissue complication probability (NTCP) calculations as a means to compare proton and photon plans and evaluation of clinical appropriateness of calculated values. Int J Cancer 2000, 90:351-358. 10.1002/1097-0215(20001220)90:6<351::AID-IJC7>3.0.CO;2-J, 11180139.
35. Carver JR, Shapiro CL, Ng A, Jacobs L, Schwartz C, Virgo KS, Hagerty KL, Somerfield MR, Vaughn DJ. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol 2007, 25:3991-4008. 10.1200/JCO.2007.10.9777, 17577017.
36. Guldner L, Haddy N, Pein F, Diallo I, Shamsaldin A, Dahan M, Lebidois J, Merlet P, Villain E, Sidi D, et al. Radiation dose and long term risk of cardiac pathology following radiotherapy and anthracyclin for a childhood cancer. Radiother Oncol 2006, 81:47-56. 10.1016/j.radonc.2006.08.020, 16989913.